falintolol

RN & structure given in first source; RN refers to (anti-(R))-isomer

Also Known As:

O-(3-(tert-butylamino)-2-hydroxypropyl)cyclopropyl methyl ketone oxime; falintolol oxalate, anti-(R); falintolol oxalate, anti-(S); falintolol oxalate, syn(R); falintolol oxalate, syn-(S); falintolol, anti-(S); falintolol, syn-(R); falintolol, syn-(S)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Amino Alcohols: 20
    - Propanolamines: 4
      - falintolol: 1
- Alcohols: 595
  - Amino Alcohols: 20
    - Propanolamines: 4
      - falintolol: 1
  - Propanols: 3
    - Propanolamines: 4
      - falintolol: 1

Related Diseases

1.	Ocular Hypertension (Glaucoma, Suspect) 01/01/1987 - "Changes in intraocular pressure (IOP) following topical administration of falintolol (0.5%-0.25%), a new beta-blocking agent, were studied in conscious albino rabbits with alpha-chymotrypsin-induced ocular hypertension. "
2.	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/01/1987 - "The results show that falintolol does not produce any noteworthy side effects and is capable of being an effective beta-blocking agent in open-angle glaucoma therapy."
3.	Glaucoma 01/01/1987 - "Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma." 01/01/1987 - "Since topical ocular application of beta-adrenergic antagonists useful in glaucoma therapy can also cause a number of troublesome systemic side effects, several conclusive preclinical investigations were carried out with falintolol. "

Related Drugs and Biologics

1.	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)
2.	alpha-chymotrypsin

Related Therapies and Procedures

1.	Therapeutics
2.	Topical Administration